Wapnick Pamela — SEC Form 4 filings
SEC reporting owner CIK 1995657. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-04-03 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 9 filings — 20,736 shares, $41,225 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 6,265 shares @ $2.88 ($18,043) in Metagenomi Therapeutics, Inc., filed 2024-09-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | Chief Financial Officer | 12 | — | 9 legs · 20,736 sh · $41,225 | 7 |
Form 4 filings — Wapnick Pamela
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Metagenomi Therapeutics, Inc. (MGX) | Sale (S): 1,911 @ $1.16 | EDGAR |
| 2026-06-10 | 4 | Metagenomi Therapeutics, Inc. (MGX) | Sale (S): 2,884 @ $1.30 | EDGAR |
| 2026-04-03 | 4 | Metagenomi Therapeutics, Inc. (MGX) | Grant/award (A): 24,000 @ $0 · Grant/award (A): 144,000 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Metagenomi Therapeutics, Inc. (MGX) | Sale (S): 1,581 @ $1.60 | EDGAR |
| 2025-12-08 | 4 | Metagenomi, Inc. (MGX) | Sale (S): 1,576 @ $1.77 | EDGAR |
| 2025-12-01 | 4 | Metagenomi, Inc. (MGX) | Sale (S): 1,576 @ $1.81 · Grant/award (A): 120,000 @ $1.60 | EDGAR |
| 2025-06-09 | 4 | Metagenomi, Inc. (MGX) | Sale (S): 1,576 @ $1.75 | EDGAR |
| 2025-04-03 | 4 | Metagenomi, Inc. (MGX) | Grant/award (A): 14,000 @ $0 · Grant/award (A): 84,000 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Metagenomi, Inc. (MGX) | Sale (S): 1,808 @ $1.87 | EDGAR |
| 2024-12-06 | 4 | Metagenomi, Inc. (MGX) | Sale (S): 1,559 @ $1.86 | EDGAR |
| 2024-09-06 | 4 | Metagenomi, Inc. (MGX) | Sale (S): 6,265 @ $2.88 | EDGAR |
| 2024-04-03 | 4 | Metagenomi, Inc. (MGX) | Grant/award (A): 69,316 @ $0 · Grant/award (A): 291,450 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1995657 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →